12-10166864-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002543.4(OLR1):ā€‹c.272C>Gā€‹(p.Ala91Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)
Exomes š‘“: 0.0000034 ( 0 hom. )

Consequence

OLR1
NM_002543.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.200
Variant links:
Genes affected
OLR1 (HGNC:8133): (oxidized low density lipoprotein receptor 1) This gene encodes a low density lipoprotein receptor that belongs to the C-type lectin superfamily. This gene is regulated through the cyclic AMP signaling pathway. The encoded protein binds, internalizes and degrades oxidized low-density lipoprotein. This protein may be involved in the regulation of Fas-induced apoptosis. This protein may play a role as a scavenger receptor. Mutations of this gene have been associated with atherosclerosis, risk of myocardial infarction, and may modify the risk of Alzheimer's disease. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06435853).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OLR1NM_002543.4 linkuse as main transcriptc.272C>G p.Ala91Gly missense_variant 3/6 ENST00000309539.8 NP_002534.1 P78380-1A0A024RAU0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OLR1ENST00000309539.8 linkuse as main transcriptc.272C>G p.Ala91Gly missense_variant 3/61 NM_002543.4 ENSP00000309124.3 P78380-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461876
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 14, 2024The c.272C>G (p.A91G) alteration is located in exon 3 (coding exon 3) of the OLR1 gene. This alteration results from a C to G substitution at nucleotide position 272, causing the alanine (A) at amino acid position 91 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T;T;.;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.64
T;T;T;T;T;T
M_CAP
Benign
0.0035
T
MetaRNN
Benign
0.064
T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.7
L;.;L;L;.;.
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.6
N;N;N;N;N;D
REVEL
Benign
0.021
Sift
Benign
0.045
D;D;D;D;D;D
Sift4G
Benign
0.12
T;D;T;D;D;.
Polyphen
0.0020
B;.;.;.;.;.
Vest4
0.11
MutPred
0.37
Gain of catalytic residue at R88 (P = 0.0222);Gain of catalytic residue at R88 (P = 0.0222);Gain of catalytic residue at R88 (P = 0.0222);Gain of catalytic residue at R88 (P = 0.0222);.;.;
MVP
0.24
MPC
0.10
ClinPred
0.076
T
GERP RS
-2.5
Varity_R
0.077
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-10319463; API